molecular
diagnost
techniqu
viral
test
undergon
rapid
develop
recent
year
becom
wide
use
classic
virolog
assay
major
clinic
virolog
laboratori
repres
new
method
diagnosi
human
viral
infect
recent
new
techniqu
base
multiplex
rtpcr
amplif
follow
microarray
analysi
develop
evalu
basi
amplif
viral
genomespecif
fragment
multiplex
rtpcr
subsequ
detect
via
hybrid
microorganismspecif
bind
probe
solid
surfac
allow
simultan
detect
identif
multipl
virus
singl
clinic
sampl
manag
viral
central
nervou
system
respiratori
tract
infect
current
repres
two
main
applic
microarray
routin
virolog
practic
microarray
shown
reliabl
result
comparison
referenc
rt
pcr
assay
appear
major
interest
detect
broad
rang
respiratori
neurotrop
virus
assess
pathogen
newli
discov
neglect
virus
identif
multipl
viral
infect
clinic
sampl
despit
sever
limit
observ
differ
studi
perform
new
technolog
might
improv
clinic
manag
patient
enlarg
rang
virus
detect
particular
case
sever
infect
lead
patient
hospit
intensivecar
unit
might
also
help
prevent
nosocomi
transmiss
hospit
depart
contribut
develop
new
epidemiolog
surveil
system
viral
infect
molecular
diagnost
techniqu
viral
test
undergon
rapid
develop
recent
year
becom
wide
use
classic
virolog
assay
immunofluoresc
assay
viru
isol
cell
cultur
major
clinic
virolog
laboratori
repres
new
method
diagnosi
human
viral
infect
sensit
rapid
tradit
method
nucleic
acid
amplif
test
also
allow
detect
broader
panel
virus
clinic
specimen
recent
new
techniqu
base
multiplex
rtpcr
amplif
follow
microarray
analysi
develop
evalu
clinic
sampl
microarray
divid
highdens
lowdens
dnaprob
hybrid
technolog
highdens
microarray
test
thousand
potenti
pathogen
simultan
allow
detect
novel
previous
uncharacter
agent
yet
applic
daili
diagnosi
clinic
virolog
practic
lowdens
microarray
current
cemark
vitro
diagnosi
human
viral
diseas
new
assay
allow
rapid
detect
identif
includ
type
subtyp
broad
panel
common
newli
discov
human
viral
pathogen
use
microarray
might
improv
clinic
manag
patient
prevent
nosocomi
transmiss
hospit
depart
might
allow
develop
new
epidemiolog
survey
system
viral
infect
lowdens
microarray
technolog
base
amplif
viral
genomespecif
fragment
bp
multiplex
rt
pcr
subsequ
detect
via
hybrid
microorganismspecif
bind
probe
solid
surfac
allow
simultan
detect
identif
multipl
virus
singl
clinic
sampl
commerci
avail
microarray
amplifi
product
label
biotin
amplif
step
hybrid
respect
specif
probe
immobil
known
site
microarray
place
bottom
singl
tube
eightwel
strip
incub
streptavidinperoxidas
conjug
reagent
lead
presenc
substrat
appear
insolubl
product
hybrid
site
final
microarray
reader
pilot
specif
softwar
provid
manufactur
allow
captur
process
pictur
obtain
microarray
first
main
applic
lowdens
microarray
routin
virolog
practic
consist
diagnosi
viral
central
nervou
system
cn
infect
virus
main
aetiolog
caus
cn
infect
ahead
bacteri
fungal
caus
pcr
recogn
refer
method
diagnosi
viral
cn
infect
cerebrospin
fluid
csf
specimen
molecular
test
use
routin
diagnosi
specif
highli
sensit
allow
rapid
valuabl
detect
rna
dna
virus
present
time
diagnosi
viral
cn
infect
usual
obtain
combin
multipl
pcr
rtpcr
assay
result
laboratori
confirm
c
physiciandiagnos
case
failur
explain
inconsist
small
volum
csf
avail
wide
rang
virus
potenti
respons
cn
infect
well
genet
characterist
dna
rna
virus
also
complic
rapid
larg
virolog
diagnosi
use
monoplex
rtpcr
pcr
assay
altern
multiplex
pcr
approach
follow
microarray
analysi
allow
optim
detect
neurotrop
virus
previous
publish
microarray
show
concord
result
singl
endpoint
pcr
test
use
assess
reliabl
method
recent
evalu
analyt
clinic
perform
commerci
avail
multiplex
rtpcr
dna
microarray
allow
rapid
simultan
detect
nine
dna
rna
neurotrop
virusesherp
simplex
viru
type
herp
simplex
viru
type
varicella
zoster
viru
cytomegaloviru
epsteinbarr
viru
human
herpesviru
type
human
herpesviru
type
human
herpesviru
type
enteroviru
ev
singl
csf
sampl
evalu
conduct
first
phase
test
profici
sampl
european
profici
panel
qualiti
control
molecular
diagnost
glasgow
uk
second
phase
test
csf
specimen
patient
hospit
cn
infect
previous
test
standard
commerci
avail
pcr
rtpcr
assay
neurotrop
viru
detect
microarray
demonstr
limit
detect
copi
ml
six
herpesvirus
test
qualiti
control
molecular
diagnost
avail
human
herpesviru
type
lower
sensit
copi
ml
ev
detect
result
similar
record
particip
extern
qualiti
assess
programm
whatev
molecular
techniqu
use
retrospect
analysi
csf
sampl
initi
test
posit
either
herpesvirus
ev
standard
commerci
avail
rtpcr
pcr
assay
confirm
reliabl
diagnosi
cn
infect
microarray
herpesvirusposit
sampl
evposit
csf
sampl
test
posit
interestingli
microarray
detect
ev
mix
infect
among
paediatr
asept
mening
case
initi
relat
ev
detect
confirm
quantit
realtim
pcr
assay
demonstr
viral
load
rang
genom
copi
per
millilitr
csf
mean
valu
copiesml
wherea
ev
well
known
neurotrop
virus
infect
remain
neglect
topic
statist
analys
demograph
clinic
therapeut
characterist
reveal
ev
mix
infect
caus
significantli
longer
length
stay
hospit
children
suffer
asept
mening
infect
ev
alon
lack
correl
detect
csf
leukocyt
count
suggest
dna
activ
replic
viru
latent
dna
carri
inflammatori
cell
moreov
csf
sampl
routin
submit
virolog
laboratori
neurotrop
viru
detect
march
may
epidemiolog
link
suggest
outbreak
infect
establish
preliminari
data
led
question
role
ev
mening
cofactor
associ
increas
sever
diseas
final
first
descript
combin
ev
infect
highlight
advantag
microarray
technolog
detect
mix
viral
cn
infect
well
investig
pathogen
neglect
virus
second
main
applic
microarray
manag
respiratori
tract
infect
rti
recent
conduct
two
studi
aim
evalu
technolog
virolog
diagnosi
rti
first
prospect
test
nasal
swab
nasopharyng
aspir
adult
paediatr
patient
visit
reim
univers
medic
centr
northern
franc
influenzalik
ill
therefor
rapid
reliabl
screen
larg
panel
respiratori
virus
respons
ili
major
epidemiolog
clinic
interest
monitor
influenza
pandem
wave
ninetyf
respiratori
sampl
collect
octob
test
combin
two
commerci
avail
microarray
allow
rapid
detect
influenza
viru
strain
includ
new
strain
respiratori
virus
virus
detect
respiratori
sampl
test
microarray
agreement
result
realtim
rtpcr
assay
influenza
detect
sampl
wherea
rhinovirus
parainfluenza
virus
import
caus
ili
preval
respect
moreov
use
microarray
reveal
ten
mix
infect
mainli
influenza
coronaviru
human
bocaviru
hbov
human
respiratori
syncyti
viru
hrsv
human
rhinovirus
hrv
microarray
technolog
thu
appear
major
interest
clinic
virolog
practic
rapid
accur
diagnosi
patient
suffer
ili
caus
larg
rang
respiratori
virus
second
studi
applic
microarray
assess
diagnosi
epidemiolog
survey
viral
infect
infant
hospit
bronchiol
bronchiol
import
manifest
viral
rti
larg
varieti
viral
pathogen
notabl
hrsv
implic
major
hospit
case
variabl
contribut
hrv
adenoviru
adv
human
metapneumoviru
hmpva
human
metapneumoviru
b
hmpvb
influenza
viru
type
influenza
viru
type
b
parainfluenza
viru
type
parainfluenza
viru
type
parainfluenza
viru
type
addit
nonconvent
pathogen
emerg
newli
identifi
coronavirus
hrvc
hbov
associ
sever
acut
bronchiol
case
one
hundr
thirtyeight
nasopharyng
aspir
collect
octob
septemb
test
direct
immunofluoresc
viral
cultur
combin
referenc
rtpcr
commerci
avail
microarray
allow
rapid
simultan
detect
dna
rna
human
respiratori
virus
one
virus
detect
specimen
microarray
similar
result
obtain
referenc
rt
pcr
assay
expect
global
detect
rate
appear
higher
microarray
classic
techniqu
direct
immunofluoresc
viru
isol
vs
p
even
common
respiratori
virus
hrsvab
microarray
analysi
confirm
hrsva
hrsvb
hbov
adv
hmpva
hmpvb
hrv
frequent
detect
virus
bronchiol
case
microarray
also
identifi
mix
rti
wherea
none
detect
classic
techniqu
common
associ
hrsvab
hbov
hrsvab
adv
hrsvab
furthermor
screen
clinic
specimen
microarray
appear
major
epidemiolog
interest
monitor
circul
virus
respons
bronchiol
hospit
infant
addit
classic
epidem
circul
hrsvab
winter
season
microarray
show
concomit
epidem
circul
adv
hbov
hmpvab
hrv
ev
result
major
mix
rti
detect
moreov
epidemiolog
survey
conduct
period
year
show
spring
peak
hbov
infect
detect
use
convent
techniqu
result
obtain
microarray
influenc
viru
speci
impact
mix
viral
infect
bronchiol
sever
analys
statist
analys
reveal
none
bronchiol
sever
criteria
includ
intensivecar
unit
admiss
suppli
satur
percentag
length
length
stay
hospit
significantli
increas
case
mix
infect
compar
singl
infect
specif
viral
combin
associ
sever
diseas
infant
infect
hrsv
stay
longer
hospit
howev
given
larg
panel
multipl
viral
infect
detect
microarray
multicentr
studi
necessari
assess
whether
specif
viral
associ
could
confer
elev
risk
sever
bronchiol
regard
practic
aspect
analys
perform
microarray
could
perform
total
nucleic
acid
extract
obtain
aliquot
clinic
specimen
kit
evalu
run
time
amplif
multiplex
rtpcr
h
time
need
hybrid
pcr
product
h
microarray
scan
analysi
carri
within
min
summari
total
time
need
complet
assay
c
h
specimen
extract
microarray
detect
allow
laboratori
provid
answer
clinician
singl
work
day
moreov
sampl
analys
accuraci
microarray
analysi
control
extract
amplif
intern
control
hybrid
least
three
probe
per
amplifi
target
detect
sever
limit
microarray
observ
differ
studi
perform
numer
handl
step
requir
analysi
opportun
autom
remain
limit
moreov
commerci
avail
microarray
use
without
microarray
reader
pilot
specif
softwar
provid
manufactur
limit
implement
kit
virolog
laboratori
comparison
onestep
realtim
pcr
assay
frequent
use
current
molecular
virolog
diagnosi
major
drawback
techniqu
handl
amplicon
although
contamin
event
observ
evalu
potenti
risk
contamin
could
rule
final
microarray
technolog
multiplex
endpoint
pcr
system
allow
quantit
viral
load
clinic
sampl
assum
quantit
viral
nucleic
acid
csf
sampl
may
use
monitor
effect
antivir
therapi
establish
prognosi
cn
infect
moreov
although
diagnost
valu
viral
load
nasopharyng
aspir
remain
unclear
quantif
respiratori
virus
may
provid
import
inform
influenc
viral
load
diseas
sever
role
viral
pathogen
singl
multipl
rti
henc
case
mix
viral
rti
specif
virus
detect
classic
techniqu
possibl
determin
viru
predomin
could
consid
aetiolog
agent
demonstr
whether
viru
detect
could
link
begin
ongo
past
viral
rti
place
new
technolog
virolog
laboratori
could
vari
accord
aim
analys
perform
routin
virolog
practic
assay
consid
thirdlin
test
rapid
antigen
test
rat
monoplex
rt
pcr
assay
enlarg
rang
virus
detect
particular
case
sever
infect
lead
patient
hospit
intensivecar
unit
fig
anoth
possibl
could
use
directli
rat
order
confirm
first
posit
result
obtain
case
neg
result
rat
perform
enlarg
virolog
screen
clinic
sampl
fig
final
microarray
could
use
firstlin
test
detect
viral
pathogen
last
possibl
provid
rapid
costeffici
result
physician
limit
nation
centr
infecti
diseas
control
part
epidemiolog
survey
fig
conclus
microarray
current
allow
rapid
reliabl
detect
broad
rang
respiratori
neurotrop
virus
well
identif
singl
multipl
viral
infect
clinic
sampl
despit
lack
viru
quantit
provid
rapid
type
subtyp
viral
strain
use
clinic
practic
epidemiolog
survey
none
author
present
manuscript
commerci
associ
might
pose
conflict
interest
eg
pharmaceut
stock
ownership
consult
